Rock Springs Capital Management LP Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$3.9B
Holdings
113
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (113 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | AMLXAMYLYX PHARMACEUTICALS INC | 1,011,412 | $2.9T | 72925.17% | |
| 102 | TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | 3,250,000 | $2.8T | 72142.35% | |
| 103 | BMEABIOMEA FUSION INC | 181,147 | $2.7T | 68754.86% | |
| 104 | NVV1NOVAVAX INC | 537,625 | $2.6T | 65243.68% | |
| 105 | CYPHLEAP THERAPEUTICS INC | 911,937 | $2.4T | 61585.35% | |
| 106 | SPRBSPRUCE BIOSCIENCES INC | 2,609,125 | $2.1T | 52058.67% | |
| 107 | NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | 1,000,000 | $1.8T | 45882.73% | |
| 108 | VIGLVIGIL NEUROSCIENCE INC | 471,958 | $1.6T | 40859.10% | |
| 109 | XLOXILIO THERAPEUTICS INC | 1,440,759 | $1.6T | 39504.46% | |
| 110 | OKURRENEO PHARMACEUTICALS INC | 751,730 | $1.2T | 31681.16% | |
| 111 | NVRO 2.75 04/01/25NEVRO CORP | 500,000 | $473.9B | 12030.66% | |
| 112 | TLPHTALPHERA INC | 316,460 | $326.0B | 8275.37% | |
| 113 | NUVB/WSNUVATION BIO INC | 134,028 | $40.5B | 1029.31% |
PreviousPage 2 of 2